By the kēpos Science Team
If your gut health routine still revolves around generic probiotics and fibre supplements, science has some exciting news for you. Researchers have moved well beyond basic probiotic strains and are now studying the very molecules that nature designed to build a healthy gut from day one: human milk oligosaccharides (HMOs) and lactoferrin — two bioactive compounds found in human breast milk that are now available as next-generation supplements for adults.
For decades, we assumed these powerful compounds were only relevant for infants. But a growing body of clinical research is proving that HMOs and lactoferrin can reshape the adult microbiome, strengthen the gut barrier, and support immune function in ways that traditional prebiotics simply cannot match. Here are five science-backed reasons why HMOs are changing the game for adult gut health.
1. HMOs Selectively Feed the Best Bacteria in Your Gut
Not all prebiotics are created equal. Traditional options like inulin, FOS, and GOS broadly stimulate a range of gut bacteria — including some you may not want to encourage. HMOs are different. They are precision prebiotics that selectively promote the growth of beneficial Bifidobacterium species while simultaneously reducing potentially harmful bacteria.
In a landmark randomised controlled trial, Elison et al. (2016) supplemented 100 healthy adults with two key HMOs — 2’-fucosyllactose (2’-FL) and lacto-N-neotetraose (LNnT) — for two weeks. The results were striking: participants experienced significant increases in Bifidobacterium abundance and a notable reduction in Firmicutes and Proteobacteria, two phyla associated with gut imbalance. The effect was dose-dependent and highly specific — exactly what you want from a prebiotic.
This selectivity is what sets HMOs apart. Rather than carpet-bombing your entire microbiome, HMOs act like a targeted invitation to the bacteria your gut needs most. It’s one reason brands like kēpos have built their formulations around these advanced bioactives rather than conventional fibre-based prebiotics.
2. They Help Strengthen the Gut Barrier — Your Body’s First Line of Defence
Your intestinal lining is just one cell layer thick, yet it is responsible for keeping harmful substances out of your bloodstream while allowing nutrients through. When this barrier breaks down — a condition often called “leaky gut” — the consequences can ripple across your entire body, from chronic inflammation to immune dysfunction.
Research has shown that HMOs help reinforce intestinal barrier integrity. A study by Šuligoj et al. (2020) used an advanced gut simulation model (SHIME) combined with intestinal epithelial cell cultures to demonstrate that HMOs improved barrier function in adult gut conditions, while simultaneously shifting the microbiota toward a more beneficial composition. The researchers found that HMO treatment enhanced tight junction integrity and supported mucus layer health — both critical components of a strong gut barrier.
This is also where lactoferrin enters the picture as a powerful partner. Lactoferrin, an iron-binding glycoprotein naturally present in human milk, has been shown to upregulate tight junction proteins including claudin-1, occludin, and ZO-1, which are the molecular “seals” that hold intestinal cells together (Zhao et al., 2019). When HMOs and lactoferrin work in tandem, they address gut barrier health from both the microbial and the structural side — a dual-action approach that no single probiotic strain can replicate.
3. HMOs May Help Reduce Gut Inflammation
Chronic, low-grade gut inflammation is increasingly recognised as a root driver of digestive discomfort, metabolic issues, and even mental health challenges. The exciting news? HMOs have demonstrated anti-inflammatory properties that go beyond what typical prebiotics offer.
In a preclinical study, Grabinger et al. (2019) found that oral supplementation with 2’-FL — the most abundant HMO in human breast milk — alleviated intestinal inflammation in a Crohn’s disease-like mouse model. The HMO treatment modulated the gut microbiota and reduced inflammatory markers, suggesting that HMOs may help manage inflammatory conditions by restoring microbial balance rather than simply suppressing symptoms.
This is a fundamentally different approach to inflammation management. Instead of treating the fire, HMOs help address the conditions that started it. For the approximately 70–80% of your immune system that resides in your gut (Wiertsema et al., 2021), keeping inflammation in check is not just a digestive issue — it is a whole-body priority.
4. The HMO + Lactoferrin Synergy Is a Game Changer
Here is where the science gets truly compelling. While HMOs and lactoferrin are each impressive on their own, their combined effect creates a synergy that addresses gut health from multiple angles simultaneously.
HMOs reshape the microbiome from the bottom up — selectively feeding beneficial bacteria, crowding out harmful species, and producing short-chain fatty acids that nourish intestinal cells. Lactoferrin operates through complementary mechanisms: it binds iron to starve pathogenic bacteria, directly modulates immune cell activity, and physically strengthens the gut lining.
As Legrand (2016) detailed in a comprehensive review, lactoferrin acts as a natural immune modulator with antimicrobial, anti-inflammatory, and immunoregulatory properties. It helps calibrate both innate and adaptive immune responses — dampening overreaction while still supporting the body’s ability to fight infection. Meanwhile, Ochoa & Sizonenko (2017) highlighted lactoferrin’s direct antimicrobial activity and its ability to promote beneficial gut flora, making it a natural complement to HMO’s prebiotic effects.
This is the philosophy behind effera™, a next-generation recombinant human lactoferrin ingredient that delivers bioidentical lactoferrin without relying on bovine sources. When paired with HMOs, effera™ creates a comprehensive gut health strategy that simultaneously:
- Rebuilds a healthy microbiome (HMOs)
- Strengthens the physical gut barrier (lactoferrin)
- Modulates immune function (both)
- Reduces pathogenic bacteria (lactoferrin’s iron-binding action)
This multi-layered approach is exactly what kēpos has formulated around — combining HMOs with effera™ lactoferrin in a single supplement designed to support the full gut health ecosystem.
5. These Aren’t Just for Babies — Clinical Evidence Supports Adult Benefits
Perhaps the most important shift in thinking is this: HMOs and lactoferrin are not just infant nutrition. They are bioactive compounds with mechanisms of action that are just as relevant — and sometimes more needed — in the adult gut.
Adults face unique microbiome challenges. Stress, processed food, antibiotics, ageing, and environmental toxins all take a toll on microbial diversity and gut barrier health. The Elison et al. clinical trial confirmed that HMOs are safe and well-tolerated in adults at daily doses up to 20g, with specific, measurable improvements in microbiome composition after just two weeks (Elison et al., 2016).
Similarly, lactoferrin supplementation has shown benefits for adults across a range of outcomes. Its role in supporting immune defence, reducing inflammation, and protecting the gut lining makes it relevant for anyone dealing with digestive issues, frequent illness, or simply the everyday stressors that compromise gut health.
The convergence of these two ingredients — HMOs and lactoferrin — represents a new frontier in gut health supplementation. Rather than relying on a single probiotic strain and hoping for the best, this approach targets the root architecture of gut health: the microbiome, the barrier, and the immune system, all at once.
The Bottom Line
The science is clear: human milk bioactives like HMOs and lactoferrin are not relics of infancy — they are precision tools for building and maintaining a healthy gut at any age. From selectively boosting Bifidobacterium populations to reinforcing tight junctions, reducing inflammation, and modulating immune responses, these compounds offer something that traditional prebiotics and basic probiotic supplements simply cannot.
If you are serious about gut health, it may be time to look beyond generic supplements and toward the ingredients that nature perfected over millions of years of evolution. To explore the latest research and learn more about how HMOs and lactoferrin can support your digestive wellness, visit the kēpos blog.
References
- Elison S, Vigsnaes LK, Rindom Krogsgaard L, et al. Oral supplementation of healthy adults with 2’-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr. 2016;116(8):1356-1368. PMID: 27719686
- Šuligoj T, Vigsnæs LK, Van den Abbeele P, et al. Effects of human milk oligosaccharides on the adult gut microbiota and barrier function. Nutrients. 2020;12(9):2808. PMID: 32933181
- Grabinger T, Glaus Garzon JF, Hausmann M, et al. Alleviation of intestinal inflammation by oral supplementation with 2-fucosyllactose in mice. Front Microbiol. 2019;10:1385. PMID: 31275292
- Legrand D. Overview of lactoferrin as a natural immune modulator. J Pediatr. 2016;173 Suppl:S10-S15. PMID: 27234406
- Ochoa TJ, Sizonenko SV. Lactoferrin and prematurity: a promising milk protein? Biochem Cell Biol. 2017;95(1):22-30. PMID: 28085488
- Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ. The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies. Nutrients. 2021;13(3):886. PMID: 33803407
- Zhao X, Xu XX, Liu Y, et al. The in vitro protective role of bovine lactoferrin on intestinal epithelial barrier. Molecules. 2019;24(1):148. PMID: 30609730
About the Author: This article was written by the science team at kēpos, a gut health brand pioneering the use of human milk bioactives — including HMOs and effera™ recombinant human lactoferrin — for adult wellness. kēpos is dedicated to translating cutting-edge microbiome research into supplements that actually wo